(Total Views: 439)
Posted On: 05/08/2025 8:08:26 AM
Post# of 154593
ohm wrote:
From our Abstract:
So at 36 months we had 19.8 % OS to .7% Trodelvy OS at 30 months. Am I wrong?
Quote:
As far as I know Cyodyn hasn't released survival data for 36 months. However we do know that 5 out of 28 patients (17.8%) were alive at 4 years. Which is the closest time interval we have to Troldelvy's 30 months.
From our Abstract:
Quote:
Pooled analysis of the 3 studies showed from time of leronlimab treatment; mOS 6.8 months (95% CI: 4.4-17.7), survival at 1 yr. 41.3% (95% CI 22.7-59., 2 yr. 24.8% (95% CI:8.0-41.5), and 3 yr. 19.8% (95% CI: 3.8-35.8%).
So at 36 months we had 19.8 % OS to .7% Trodelvy OS at 30 months. Am I wrong?
(4)
(0)
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
